Hologic, Inc. (HOLX) – Financial and Strategic SWOT Analysis Review

Hologic, Inc. (HOLX) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
60
Medical Devices
United States

Hologic, Inc. (HOLX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hologic, Inc. (Hologic) is one of the leading providers of diagnostic products, medical imaging systems and surgical products. Its major products include diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company sells and services its products through a net work of direct sales and service forces and through independent distributors and sales representatives. The company operates in Americas, Europe and Asia-Pacific. Hologic is headquartered in Bedford, the US.

Hologic envisages establishing its position growing continuously and expanding its global presence; tapping into new business areas; enhancing product-mix; fostering operational excellence and flexibility; pursuing long term strategic partnerships and agreements; and strategic acquisitions of small and medium-sized enterprises that supplement the company’s existing portfolio .

Hologic, Inc. Key Recent Developments

Feb 23, 2015: Hologic’s Tepnel Pharma Services Expands Portfolio to Include Companion Diagnostic Development
Jan 28, 2015: Hologic Announces Financial Results For First Quarter Fiscal 2015
Jan 20, 2015: Hologic Announces Additions to Executive Leadership Team
Jan 13, 2015: Value Analysis Concludes the Adoption of Hologic 3D Mammography Can Save the U.S. Healthcare System Millions of Dollars
Jan 12, 2015: Hologic Preliminary Revenues Increased 7% to $653 Million in the First Quarter of Fiscal 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Hologic, Inc. – Key Facts 6
Hologic, Inc. – Key Employees 7
Hologic, Inc. – Key Employee Biographies 8
Hologic, Inc. – Major Products and Services 10
Hologic, Inc. – Medical Equipment Pipeline Products Data 13
Hologic, Inc. Pipeline Products by Equipment Type 13
Hologic, Inc. Pipeline Products by Development Stage 15
Hologic, Inc. – History 16
Hologic, Inc. – Company Statement 20
Hologic, Inc. – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Hologic, Inc. – Key Manufacturing Facilities 25
Section 2 – Company Analysis 26
Hologic, Inc. – Business Description 26
Business Description – Breast Health 26
Breast Health – Overview 26
Breast Health – Financials 26
Breast Health – Capital Expenditure 26
Breast Health – Technology 26
Business Description – Diagnostics 27
Diagnostics – Overview 27
Diagnostics – Financials 27
Diagnostics – Capital Expenditure 27
Diagnostics – Technology 27
Business Description – GYN Surgical 27
GYN Surgical – Overview 27
GYN Surgical – Financials 27
GYN Surgical – Capital Expenditure 28
GYN Surgical – Technology 28
Business Description – Skeletal Health 28
Skeletal Health – Overview 28
Skeletal Health – Financials 28
Skeletal Health – Capital Expenditure 28
Skeletal Health – Technology 28
Hologic, Inc. – Corporate Strategy 29
Hologic, Inc. – SWOT Analysis 30
SWOT Analysis – Overview 30
Hologic, Inc. – Strengths 30
Strength – Focused Research and Development Capability 30
Strength – Inorganic Growth 30
Strength – Strong Sales and Distribution Network 30
Hologic, Inc. – Weaknesses 31
Weakness – Patent Infringement Concerns 31
Weakness – Safety Issues:/Product Defects 31
Hologic, Inc. – Opportunities 32
Opportunity – Product Approvals 32
Opportunity – Growing IVD Market 32
Opportunity – Mammography Equipment Market 32
Hologic, Inc. – Threats 33
Threat – Dependence on Limited Customers 33
Threat – Highly Competitive Market 33
Threat – Dependence on Third Party Manufacturers 33
Hologic, Inc. – Key Competitors 34
Section 3 – Company Financial Ratios 35
Financial Ratios – Capital Market Ratios 35
Financial Ratios – Annual Ratios 36
Performance Chart 38
Financial Performance 38
Financial Ratios – Ratio Charts 39
Section 4 – Company’s Lifesciences Financial Deals and Alliances 40
Hologic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 40
Hologic, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 41
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 42
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 43
Hologic, Inc., Recent Deals Summary 44
Section 5 – Company’s Recent Developments 45
Feb 23, 2015: Hologic’s Tepnel Pharma Services Expands Portfolio to Include Companion Diagnostic Development 45
Jan 28, 2015: Hologic Announces Financial Results For First Quarter Fiscal 2015 46
Jan 20, 2015: Hologic Announces Additions to Executive Leadership Team 47
Jan 13, 2015: Value Analysis Concludes the Adoption of Hologic 3D Mammography Can Save the U.S. Healthcare System Millions of Dollars 48
Jan 12, 2015: Hologic Preliminary Revenues Increased 7% to $653 Million in the First Quarter of Fiscal 2015 49
Dec 31, 2014: Women’s Digital Imaging Adds Low-Dose Breast Tomosynthesis, 3-D Mammography, with C-View 2-D Imaging Software to Reduce Radiation to Level of Standard Mammogram 50
Dec 17, 2014: NICE issues draft diagnostics guidance on prostate cancer tests 51
Dec 01, 2014: Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test 52
Nov 05, 2014: Hologic Announces Fourth Quarter Fiscal 2014 Operating Results 53
Aug 06, 2014: Hologic’s Horizon DXA Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment Receives Regulatory Approval in Canada 55
Section 6 – Appendix 56
Methodology 56
Ratio Definitions 56
About GlobalData 60
Contact Us 60
Disclaimer 60



List of Tables
Hologic, Inc., Key Facts 6
Hologic, Inc., Key Employees 7
Hologic, Inc., Key Employee Biographies 8
Hologic, Inc., Major Products and Services 10
Hologic, Inc. Number of Pipeline Products by Equipment Type 13
Hologic, Inc. Pipeline Products by Equipment Type 14
Hologic, Inc. Number of Pipeline Products by Development Stage 15
Hologic, Inc. Pipeline Products by Development Stage 15
Hologic, Inc., History 16
Hologic, Inc., Other Locations 22
Hologic, Inc., Subsidiaries 23
Hologic, Inc., Key Manufacturing Facilities 25
Hologic, Inc., Key Competitors 34
Hologic, Inc., Ratios based on current share price 35
Hologic, Inc., Annual Ratios 36
Hologic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 40
Hologic, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 41
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 42
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 43
Hologic, Inc., Recent Deals Summary 44
Currency Codes 56
Capital Market Ratios 56
Equity Ratios 57
Profitability Ratios 57
Cost Ratios 58
Liquidity Ratios 58
Leverage Ratios 59
Efficiency Ratios 59



List of Figures
Hologic, Inc. Pipeline Products by Equipment Type 13
Hologic, Inc. Pipeline Products by Development Stage 15
Hologic, Inc., Performance Chart (2010 – 2014) 38
Hologic, Inc., Ratio Charts 39
Hologic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 40
Hologic, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 41
Hologic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 42
Hologic, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 43

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.